BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 17530316)

  • 1. Ischemic preconditioning targets the reperfusion phase.
    Hausenloy DJ; Wynne AM; Yellon DM
    Basic Res Cardiol; 2007 Sep; 102(5):445-52. PubMed ID: 17530316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection.
    Hausenloy D; Wynne A; Duchen M; Yellon D
    Circulation; 2004 Apr; 109(14):1714-7. PubMed ID: 15066952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
    Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-conditioning induced cardioprotection requires signaling through a redox-sensitive mechanism, mitochondrial ATP-sensitive K+ channel and protein kinase C activation.
    Penna C; Rastaldo R; Mancardi D; Raimondo S; Cappello S; Gattullo D; Losano G; Pagliaro P
    Basic Res Cardiol; 2006 Mar; 101(2):180-9. PubMed ID: 16450075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial K(ATP) channel opening is important during index ischemia and following myocardial reperfusion in ischemic preconditioned rat hearts.
    Fryer RM; Hsu AK; Gross GJ
    J Mol Cell Cardiol; 2001 Apr; 33(4):831-4. PubMed ID: 11273735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ischemia-selective KATP channel antagonist, 5-hydroxydecanoate, blocks ischemic preconditioning in the rat heart.
    Schultz JE; Qian YZ; Gross GJ; Kukreja RC
    J Mol Cell Cardiol; 1997 Mar; 29(3):1055-60. PubMed ID: 9152866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart.
    Das B; Sarkar C
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):277-86. PubMed ID: 16495767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase).
    Lecour S; Suleman N; Deuchar GA; Somers S; Lacerda L; Huisamen B; Opie LH
    Circulation; 2005 Dec; 112(25):3911-8. PubMed ID: 16344382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of C-reactive protein in ischemia/reperfusion injury and preconditioning in a rat model of myocardial infarction.
    Valtchanova-Matchouganska A; Gondwe M; Nadar A
    Life Sci; 2004 Jul; 75(8):901-10. PubMed ID: 15193950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible involvement of PKC-delta in the abrogated cardioprotective potential of ischemic preconditioning in hyperhomocysteinemic rat hearts.
    Rohilla A; Singh G; Singh M; Bala kumar P
    Biomed Pharmacother; 2010 Mar; 64(3):195-202. PubMed ID: 19914792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium.
    Baines CP; Goto M; Downey JM
    J Mol Cell Cardiol; 1997 Jan; 29(1):207-16. PubMed ID: 9040035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemic preconditioning in immature hearts: mechanism and compatibility with cardioplegia.
    Zhu B; Min S; Long C; Ye T
    Chin Med J (Engl); 2003 Feb; 116(2):253-7. PubMed ID: 12775242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling.
    Penna C; Mancardi D; Rastaldo R; Losano G; Pagliaro P
    Cardiovasc Res; 2007 Jul; 75(1):168-77. PubMed ID: 17400201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium preconditioning, but not ischemic preconditioning, bypasses the adenosine triphosphate-dependent potassium (KATP) channel.
    Meldrum DR; Cain BS; Meng X; Cleveland JC; Shames BD; Donnahoo KK; Banerjee A; Harken AH
    J Surg Res; 1999 Jul; 85(1):77-82. PubMed ID: 10383841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pivotal role of NOX-2-containing NADPH oxidase in early ischemic preconditioning.
    Bell RM; Cave AC; Johar S; Hearse DJ; Shah AM; Shattock MJ
    FASEB J; 2005 Dec; 19(14):2037-9. PubMed ID: 16236999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The platelet activating factor triggers preconditioning-like cardioprotective effect via mitochondrial K-ATP channels and redox-sensible signaling.
    Penna C; Mognetti B; Tullio F; Gattullo D; Mancardi D; Pagliaro P; Alloatti G
    J Physiol Pharmacol; 2008 Mar; 59(1):47-54. PubMed ID: 18441387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bradykinin protects against infarction but does not mediate ischemic preconditioning in the isolated rat heart.
    Bugge E; Ytrehus K
    J Mol Cell Cardiol; 1996 Dec; 28(12):2333-41. PubMed ID: 9004150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological preconditioning by levosimendan is mediated by inducible nitric oxide synthase and mitochondrial KATP channel activation in the in vivo anesthetized rabbit heart model.
    Das B; Sarkar C
    Vascul Pharmacol; 2007 Oct; 47(4):248-56. PubMed ID: 17728191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling.
    Zatta AJ; Kin H; Lee G; Wang N; Jiang R; Lust R; Reeves JG; Mykytenko J; Guyton RA; Zhao ZQ; Vinten-Johansen J
    Cardiovasc Res; 2006 May; 70(2):315-24. PubMed ID: 16443207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection.
    Fryer RM; Pratt PF; Hsu AK; Gross GJ
    J Pharmacol Exp Ther; 2001 Feb; 296(2):642-9. PubMed ID: 11160653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.